• FirefoxInstall the new Firefox »
  •  Dow Down 0.23% Nasdaq Down 0.27%

    CytRx Corporation (CYTR)

    -NasdaqCM
    3.35 Down 0.16(4.56%) Mar 26, 4:00PM EDT
    Add to Portfolio
    Prev Close:3.51
    Open:3.46
    Bid:3.00 x 100
    Ask:3.86 x 1000
    1y Target Est:10.00
    Beta:1.26
    Earnings Date:Apr 29 - May 4 (Est.)
    Day's Range:3.30 - 3.48
    52wk Range:2.08 - 5.46
    Volume:800,041
    Avg Vol (3m):1,307,460
    Market Cap:186.67M
    P/E (ttm):N/A
    EPS (ttm):-0.55
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CYTR

    Comparison

    Symbol% ChgMkt Cap
    CYTRDown 4.56%186.67M
    LLYDown 1.24%77.89B
    NVSDown 0.80%238.81B
    SNYDown 2.98%127.61B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):1,955.84
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.98
    Quarterly EPS Est (Mar-15) :-0.24
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    CytRx Corporation operates as a biopharmaceutical research and development company specializing in oncology. The company’s product candidate includes aldoxorubicin that has completed Phase IIb clinical trial as a first-line therapy for soft t... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback